Robert W. Duggan - 09 May 2023 Form 4 Insider Report for Pulse Biosciences, Inc. (PLSE)

Role
Director, 10%+ Owner
Signature
/s/ Robert W. Duggan
Issuer symbol
PLSE
Transactions as of
09 May 2023
Net transactions value
+$65,249,320
Form type
4
Filing time
10 May 2023, 17:41:30 UTC
Previous filing
08 Mar 2023
Next filing
06 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLSE Common Stock Purchase $65,249,320 +10,022,937 +49% $6.51 30,414,661 09 May 2023 Direct F1
holding PLSE Common Stock 411,044 09 May 2023 footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were acquired pursuant to the terms of that certain purchase agreement by and between the Reporting Person and the Issuer, of which consideration included the satisfaction of a loan from the Reporting Person to the Issuer.
F2 Shares are held by Genius Inc., of which the Reporting Person is the sole shareholder.